Latest medical news: Sotorasibu is on the market, the latest price is at a glance!

Sotorasib (Sotorasib) is an innovative anti-cancer drug used to treat non-small cell lung cancer (NSCLC). What makes it special is that it targets a specific genetic mutation called KRAS G12C, which is common in many cancers, especially NSCLC.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.

KRAS G12C mutation leads to abnormal activation of intracellular signaling pathways and promotes uncontrolled proliferation of tumor cells. By binding to the specific point of this mutation, sotoracib blocks abnormal signaling pathways and inhibits the growth and spread of cancer cells.

This drug is unique in that it breaks through KRAS gene mutations that have long been considered difficult to intervene, filling an important gap in the field of cancer treatment. Patients with NSCLC with KRAS G12C mutations, especially those at advanced stages, often face limited treatment options due to the lack of effective targeted therapy options.

Sotoraxib is an oral medication that patients take orally in prescribed doses as recommended by their doctor. Before starting treatment, genetic testing is usually required to confirm whether the patient carries theKRAS G12Cmutation to ensure the effectiveness of the drug.

Preliminary clinical trial results show that sotoraxib demonstrated significant efficacy in some patients, including partial or complete responses to cancer. However, like all medications, sotoraxib may cause some side effects, including but not limited to lung problems, abnormal liver function, and eye problems.